# US 2016/0362698 A1 · Method for Stable Gene-Amplification in a Bacterial Host Cell

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0362698 A1
- Document ID: US20160362698A1
- Status: Published application
- Kind: A1
- Application number: 15/252,548
- Filed: 2016-08-31
- Published: 2016-12-15
- Earliest claimed: 2003-10-31
- Assignees: Novozymes A/S
- Applicants: Novozymes A/S
- Inventors: Carsten Olsen; Michael Dolberg Rasmussen
- Web page: https://patentgrep.com/patent/US20160362698A1

## CPC

- C12N 15/75: for Bacillus
- C12N 9/1007: {Methyltransferases (general) (2.1.1.)}
- C12N 9/2471: {Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase}
- C12P 21/00: Preparation of peptides or proteins (single cell protein C12N1/00)
- C12Y 201/01014: 5-Methyltetrahydropteroyltriglutamate--homocysteine S-methyltransferase (2.1.1.14)
- C12Y 302/01023: Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

A bacterial host cell is disclosed including at least two copies of an amplification unit in its genome, the amplification unit including: i) at least one copy of a gene of interest, and ii) an expressible conditionally essential gene, wherein the conditionally essential gene is either promoterless or transcribed from a heterologous promoter having an activity substantially lower than the endogenous promoter of the conditionally essential gene, and wherein the conditionally essential gene if not functional would render the cell auxotrophic for at least one specific substance or unable to utilize one or more specific sole carbon source; methods for producing a protein using the cell of the invention, and methods for constructing the cell of the invention.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A bacterial host cell comprising at least two copies of an amplification unit in its genome, said amplification unit comprising:
(a) at least one copy of a gene of interest, and
(b) an expressible conditionally essential gene, wherein the conditionally essential gene is either promoterless or transcribed from a heterologous promoter having an activity substantially lower than the endogenous promoter of said conditionally essential gene, wherein the conditionally essential gene encodes an enzyme required for xylose, gluconate, glycerol or arabinose utilization and wherein the conditionally essential gene if not functional would render the cell auxotrophic for at least one specific substance or unable to utilize xylose, gluconate, glycerol or arabi nose.

### Claim 22 (depends on 21)

The cell of claim 21, wherein the bacterial host cell is a gram-positive cell.

### Claim 23 (depends on 21)

The cell of claim 21, wherein the bacterial host cell is a Bacillus host cell.

### Claim 24 (depends on 21)

The cell of claim 21, wherein the gene of interest encodes an enzyme with an activity selected from the group consisting of aminopeptidase, amylase, amyloglucosidase, carbohydrase, carboxypeptidase, catalase, cellulase, chitinase, cutinase, cyclodextrin glycosyltransferase, deoxyribonuclease, esterase, galactosidase, beta-galactosidase, glucoamylase, glucose oxidase, glucosidase, haloperoxidase, hemicellulase, invertase, isomerase, laccase, ligase, lipase, lyase, mannosidase, oxidase, pectinase, peroxidase, phytase, phenoloxidase, polyphenoloxidase, protease, ribonuclease, transferase, transglutaminase, or xylanase.

### Claim 25 (depends on 21)

The cell of claim 21, wherein the gene of interest encodes an antimicrobial peptide.

### Claim 26 (depends on 21)

The cell of claim 21, wherein the gene of interest encodes a peptide with biological activity in the human body.

### Claim 27 (depends on 21)

The cell of claim 21, wherein the amplification unit further comprises an antibiotic selection marker.

### Claim 28 (depends on 21)

The cell of claim 21, wherein the amplification unit further comprises a resolvase site or res-site.

### Claim 29 (depends on 21)

The cell of claim 21, wherein the conditionally essential gene is transcribed from a heterologous promoter having an activity level, when compared with the endogenous promoter of the conditionally essential gene, which is reduced by a factor or 2 to 100.

### Claim 30 (depends on 21)

The cell of claim 21, wherein the conditionally essential gene is promoterless.

### Claim 31 (depends on 30)

The cell of claim 30, wherein the gene of interest is located upstream of the conditionally essential gene in the amplification unit, and wherein the gene of interest and the conditionally essential gene are co-directionally transcribed.

### Claim 32 (depends on 31)

The cell of claim 31, wherein the conditionally essential gene is expressed by read-through transcription from the gene of interest.

### Claim 33 (depends on 21)

A method for producing a protein encoded by a gene of interest, comprising
(a) culturing the bacterial host cell of claim 21; and
(b) recovering the protein.

### Claim 34 (depends on 33)

The method of claim 33, wherein the conditionally essential gene is at least 95% identical to a hemA sequence of Bacillus licheniformis.

### Claim 35 (depends on 33)

The method of claim 33, wherein the conditionally essential gene is at least 97% identical to a hemA sequence of Bacillus licheniformis.

### Claim 36 (depends on 33)

The method of claim 33, wherein the conditionally essential gene is a hemA sequence of Bacillus licheniformis.

### Claim 37 (depends on 33)

The method of claim 33, wherein the bacterial host cell is a Bacillus host cell.
